AR-C118925XX
Selleck Chemicals
SKU:E6653-1MG
Couldn't load pickup availability

AR-C118925XX is an antagonist linked to MAPK / ERK Signaling and related pathway-oriented research. In practice, this places the compound in experiments that measure mitogenic kinase cascades, proliferation control, and differentiation-linked signaling in biochemical and cell-based models.
The pathway annotation connects AR-C118925XX to MAPK / ERK Signaling, supporting experiments that monitor mitogenic kinase cascades, proliferation control, and differentiation-linked signaling across biochemical, cellular, or phenotypic assay formats. This context is compatible with phosphorylation mapping, pathway-response, and growth assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. When a fully resolved mechanism is unavailable, parallel readouts such as viability, reporter activity, morphology, localization, or biochemical conversion can still help position the compound experimentally.
Research Applications
- Pathway perturbation studies connected to MAPK / ERK Signaling
- Receptor-blockade and ligand-competition studies
- Combination studies with orthogonal perturbagens
- Mechanism-oriented follow-up using biochemical and cellular endpoints
Overall, AR-C118925XX is well suited to pathway-oriented studies that need a defined compound input for MAPK / ERK Signaling readouts in biochemical and cell-based models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Pathways:
- MAPK / ERK Signaling
- CAS No.:
- 216657-60-2
- Molecular Weight:
- 537.59
- Formula:
- C₂₈H₂₃N₇O₃S
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.